Microparticles and nanoparticles for drug delivery
- PMID: 17191251
- DOI: 10.1002/bit.21301
Microparticles and nanoparticles for drug delivery
Abstract
Particulate drug delivery systems have become important in experimental pharmaceutics and clinical medicine. The distinction is often made between micro- and nanoparticles, being particles with dimensions best described in micrometers and nanometers respectively. That size difference entails real differences at many levels, from formulation to in vivo usage. Here I will discuss those differences and provide examples of applications, for local and systemic drug delivery. I will outline a number of challenges of interest in particulate drug delivery.
(c) 2006 Wiley Periodicals, Inc.
Similar articles
-
Nanoparticles and microparticles as vaccine-delivery systems.Expert Rev Vaccines. 2007 Oct;6(5):797-808. doi: 10.1586/14760584.6.5.797. Expert Rev Vaccines. 2007. PMID: 17931159 Review.
-
Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles.Adv Drug Deliv Rev. 2009 Mar 28;61(3):218-25. doi: 10.1016/j.addr.2008.12.009. Epub 2009 Jan 11. Adv Drug Deliv Rev. 2009. PMID: 19168103 Review.
-
Nanoparticles for drug delivery to the lungs.Trends Biotechnol. 2007 Dec;25(12):563-70. doi: 10.1016/j.tibtech.2007.09.005. Epub 2007 Nov 8. Trends Biotechnol. 2007. PMID: 17997181 Review.
-
Materials in particulate form for tissue engineering. 1. Basic concepts.J Tissue Eng Regen Med. 2007 Jan-Feb;1(1):4-24. doi: 10.1002/term.2. J Tissue Eng Regen Med. 2007. PMID: 18038388 Review.
-
Nanoparticles and microparticles for drug and vaccine delivery.J Anat. 1996 Dec;189 ( Pt 3)(Pt 3):503-5. J Anat. 1996. PMID: 8982823 Free PMC article. Review.
Cited by
-
Size mapping of electric field-assisted production of polycaprolactone particles.J R Soc Interface. 2010 Aug 6;7 Suppl 4(Suppl 4):S393-402. doi: 10.1098/rsif.2010.0099.focus. Epub 2010 Jun 2. J R Soc Interface. 2010. PMID: 20519210 Free PMC article.
-
The Optimized Delivery of Triterpenes by Liposomal Nanoformulations: Overcoming the Challenges.Int J Mol Sci. 2022 Jan 20;23(3):1140. doi: 10.3390/ijms23031140. Int J Mol Sci. 2022. PMID: 35163063 Free PMC article. Review.
-
Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation.Int J Nanomedicine. 2019 Aug 7;14:6231-6247. doi: 10.2147/IJN.S215447. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31496683 Free PMC article.
-
Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration.Tissue Eng Part B Rev. 2019 Aug;25(4):259-290. doi: 10.1089/ten.TEB.2018.0325. Tissue Eng Part B Rev. 2019. PMID: 30896342 Free PMC article. Review.
-
Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.Int J Nanomedicine. 2019 Jun 4;14:4105-4121. doi: 10.2147/IJN.S198552. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31239670 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources